Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB-WT) Current Leases (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Current Leases for 3 consecutive years, with $1.9 million as the latest value for Q4 2025.

  • Quarterly Current Leases rose 13.05% to $1.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Dec 2025, up 13.05% year-over-year, with the annual reading at $1.9 million for FY2025, 13.05% up from the prior year.
  • Current Leases for Q4 2025 was $1.9 million at Nuvation Bio, roughly flat from $1.9 million in the prior quarter.
  • The five-year high for Current Leases was $2.1 million in Q2 2024, with the low at $1.2 million in Q1 2023.
  • Average Current Leases over 3 years is $1.8 million, with a median of $1.9 million recorded in 2025.
  • Peak annual rise in Current Leases hit 62.62% in 2024, while the deepest fall reached 15.67% in 2024.
  • Over 3 years, Current Leases stood at $2.0 million in 2023, then decreased by 15.67% to $1.7 million in 2024, then rose by 13.05% to $1.9 million in 2025.
  • According to Business Quant data, Current Leases over the past three periods came in at $1.9 million, $1.9 million, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.